Armin Ritzhaupt, is a scientific administrator in the Regulatory Affairs Office at EMA providing regulatory support to development, evaluation and surveillance of medicinal products for human use with a focus on activities related to the implementation of the new medical device and in vitro diagnostic regulations. Armin worked in industry from 2002 to 2015 in different roles in clinical development and global regulatory affairs before joining EMA. He holds PhD in biochemistry from the University of Liverpool, and a Masters of Global Public Health from the University of Manchester. He completed a postdoctoral fellowship at the Center for Biologics Evaluation and Research (CBER), FDA.